Multivariate progression analysis showed high expression of FOXM1, advanced cancer stages and poor histological differentiation (high grade) were found to be independent prognostic factors for short overall survival (95% CI, 0.906–5.754, HR 2.283, P = 0.08; 95% CI, 0.953–5.963, HR 2.384, P = 0.06; 95% CI, 2.137–40.638, HR 9.318, P = 0.003, respectively) and disease-free survival (95% CI, 1.025–6.631, HR 2.607, P = 0.04; 95% CI, 1.039–6.555, HR 2.61, P = 0.04; 95% CI, 1.821–35.091, HR 7.993, P = 0.006, respectively). This evidence concerns the gene FOXM1 and cancer.